Marathon Asset Management Ltd Sells 17,211 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Marathon Asset Management Ltd reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 261,992 shares of the company's stock after selling 17,211 shares during the quarter. Marathon Asset Management Ltd owned 0.21% of Henry Schein worth $18,130,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Clarkston Capital Partners LLC raised its position in Henry Schein by 5.4% during the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company's stock worth $101,900,000 after acquiring an additional 71,560 shares in the last quarter. Nuance Investments LLC raised its position in Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock worth $166,072,000 after acquiring an additional 414,748 shares in the last quarter. Olstein Capital Management L.P. raised its position in Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock worth $7,543,000 after acquiring an additional 16,000 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Henry Schein during the third quarter worth $515,000. Finally, Equitable Trust Co. bought a new stake in Henry Schein during the fourth quarter worth $417,000. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on HSIC. Barrington Research reaffirmed an "outperform" rating and set a $90.00 price target on shares of Henry Schein in a research report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their price objective for the company from $69.00 to $84.00 in a report on Monday, January 6th. UBS Group decreased their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. Finally, StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Henry Schein presently has an average rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Price Performance

Shares of HSIC stock traded up $1.15 on Wednesday, reaching $71.46. The company had a trading volume of 2,532,278 shares, compared to its average volume of 1,479,525. The stock has a market capitalization of $8.87 billion, a PE ratio of 29.41, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49. The business's 50-day moving average is $74.42 and its 200 day moving average is $72.51.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm's revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $0.66 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.